Orakl Oncology Company Profile: Funding, Investors & Partnerships

Orakl Oncology

Orakl Oncology leverages tumor avatars that combine best-in-class biology with high-quality clinical and molecular data at scale. Our techbio platform enables oncology players to identify relevant targets and deliver better drugs, faster. As a spin-out from the Gustave Roussy Institute, the world's 3rd best cancer center, Orakl Oncology was co-founded by a team of seasoned experts with decades of international experience in cancer cell biology and engineering.Orakl Oncology leverages tumor avatars that combine best-in-class biology with high-quality clinical Show More

Alpha Score

48.9

Total Funding$ 26.18 M